Park, I., Choi, S. J., Kim, Y. S., Ahn, H. K., Hong, J., Sym, S. J., . . . Shin, D. B. (2016). Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy. Cancer Res Treat.
Chicago Style CitationPark, Inkeun, et al. "Prognostic Factors for Risk Stratification of Patients With Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated With Gemcitabine-Based Chemotherapy." Cancer Res Treat 2016.
Cita MLAPark, Inkeun, et al. "Prognostic Factors for Risk Stratification of Patients With Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated With Gemcitabine-Based Chemotherapy." Cancer Res Treat 2016.
Atenció: Aquestes cites poden no estar 100% correctes.